Publisher： Future Science
Founded in： 2012
Total resources： 5
E-ISSN： 2046-8962
ISSN： 2046-8954
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Pharmaceutical Patent Analyst
Menu
Insights into the role of patents in R&D
Pharmaceutical Patent Analyst , Vol. 2, Iss. 6, 2013-11 , pp.
Access to resources
Recommend
Evergreening by whom? A review of secondary patents for omeprazole
Pharmaceutical Patent Analyst , Vol. 2, Iss. 6, 2013-11 , pp.Compulsory pharmaceutical patent licensing in Brazil: the controversy of public interest
By Rodrigues da Silva Caio,Galvão de Botton Leonor in (2013)
Pharmaceutical Patent Analyst , Vol. 2, Iss. 6, 2013-11 , pp.Cases Update: International roundup of recently filed cases and noteworthy rulings
By Komatani Takeshi S,Sklan Alexandra in (2013)
Pharmaceutical Patent Analyst , Vol. 2, Iss. 6, 2013-11 , pp.Discussion of PARP inhibitors in cancer therapy
By Wielgos Monica,Yang Eddy S in (2013)
Pharmaceutical Patent Analyst , Vol. 2, Iss. 6, 2013-11 , pp.Compulsory licensing issues and trends in Asia
By Rungpry Siraprapha Khim in (2013)
Pharmaceutical Patent Analyst , Vol. 2, Iss. 6, 2013-11 , pp.Patented nanomedicines for the treatment of brain tumors
By Caruso Gerardo,Raudino Giuseppe,Caffo Maria in (2013)
Pharmaceutical Patent Analyst , Vol. 2, Iss. 6, 2013-11 , pp.
Previous
Next